Literature DB >> 23815502

A modified rat model of exercise-induced renal injury and the protective effects of losartan and yishen huanji decoction.

Hong Chen1, Chun-Hua Zhou, Jun Yang.   

Abstract

We modified a rat model of exercise-induced renal injury by forcing 4-week-old male Sprague-Dawley (SD) rats (the MOD group) running on a treadmill for 8 weeks under conditions of high temperature, high humidity, bearing weight with some additional stimulations. Compared with the control (CON) group, the traditional running group (TRA), the losartan potassium intervention running group (LOS) and the traditional Chinese medicine "Yishen Huanji Decoction" intervention running group (CHI), the urinary, biochemistry indicators, the concentrations of angiotensin II (Ang II) were significantly higher in the MOD group than in the TRA group. After 3--4 weeks and 8-week training program, the 24-h urine protein and NAG levels in the LOS group and CHI group were lower than in the MOD group respectively. The BUN and SCr levels in the CHI group were lower than in the MOD group and higher than in the LOS group. AngII concentrations in the LOS group were higher than the MOD group. The modified rat renal injury model induced greater lesions than the traditional model. High temperatures, humidity and weight bearing were critical factors to induce Ang II activation, which can aggravate renal injury. Losartan potassium and the "Yishen Huanji Decoction" can protect against renal injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815502     DOI: 10.3109/0886022X.2013.808536

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  1 in total

1.  Protective Role of Angiotensin II Type 1 Receptor Blocker on Short Time Effect of Oleic Acid Induced Lung and Kidney Injury.

Authors:  Ardeshir Talebi; Fatemeh Emami; Reza Biranvand; Zahra Moosavi; Kimia Ramtin; Soheil Sadeghi; Kimia Baghaei; Zahra Lak; Mehdi Nematbakhsh
Journal:  Int J Prev Med       Date:  2021-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.